Vineti, Inc., digital traceability and orchestration solution for cell and gene therapies, and World Courier, a part of AmerisourceBergen and a global leader in specialty logistics, today announced a partnership to further extend the reach of cell and gene therapies world-wide.

Together, Vineti and World Courier will offer a holistic, integrated logistics and supply chain solution that will enable cell and gene therapy developers to scale their treatments, care networks, and manufacturing quickly and safely. Both companies have significant experience supporting commercial therapies, and are well-positioned to help market-ready and in-market therapies scale. 

The Vineti digital "platform of record" powers next-generation therapies by aligning, tracking, and documenting the entire cell therapy process, from ordering and logistics to manufacturing and clinical data. Vineti's software solution supports all the major stakeholders in the cell and gene therapy ecosystem, helping everyone from healthcare providers to biopharma and manufacturers exert efficiency and control.

When combined with World Courier's global network of 140+ company-owned offices operating across more than 50 countries, the resulting partnership will drive faster access to cell and gene therapies, with scalable supply chain solutions anchored in top-tier safety and compliance.

Sam Herbert, president of World Courier, commented, "Offering Vineti's digital platform of record bolsters the options available within our global logistics platform, offering a wider choice for cell and gene therapy developers to trace, orchestrate and scale their products. We're pleased to be working together to realize the full potential of cell and gene therapies for both patients and manufacturers."

The Vineti-World Courier solution will be offered through World Courier's global network, as well as directly through Vineti's business development team.

(Source: Vineti, Inc.)